Olanrewaju Ayodeji Durojaye

9PUBLICATIONS
6CO-AUTHORS
Predictive and prognostic markersMicrofluidics and nanofluidicsComputational neuroscience (incl. mathematical neuroscience and theoretical neuroscience)Urban planning and healthOral and maxillofacial surgery
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 22, 2025
CCL18 and EGF May Serve as Potential Prognostic Biomarkers and Therapeutic Targets for Human Breast Cancer.

Sm Faysal Bellah, Fatema Akter Sonia, Md Razowanul Ferdous

|Apr 16, 2024
An in silico LLPS perturbation approach in the design of a novel SARS-CoV-2 spike receptor-binding domain inhibitor.

Olanrewaju Ayodeji Durojaye, Divine Mensah Sedzro, Talifhani Mushiana

|Apr 16, 2024
Potential therapeutic target identification in the novel 2019 coronavirus: insight from homology modeling and blind docking study.

Olanrewaju Ayodeji Durojaye, Talifhani Mushiana, Henrietta Onyinye Uzoeto

|Apr 16, 2024
An in silico epitope-based peptide vaccine design against the 2019-nCoV.

Olanrewaju Ayodeji Durojaye, Talifhani Mushiana, Samuel Cosmas

|Jul 31, 2023
Oral cavity infection by the SARS-CoV-2: emphasizing the essence of masking and peptide therapeutics.

Glory Omini Ibiang, Joseph Malachi, Mercy Omini Ibiang

|Jun 24, 2022
A New Variant of Mutational and Polymorphic Signatures in the ERG11 Gene of Fluconazole-Resistant Candida albicans.

Arome Solomon Odiba, Olanrewaju Ayodeji Durojaye, Ifeoma Maureen Ezeonu

Pageof 2